Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter Study
J. Ceravalls, A.M. Giménez-Arnau, V. Expósito-Serrano, N. Fernández Chico, A. Lara Moya, I. Bielsa, P. Ribó, B. Mascaró-Hereza, M. Bonfill-Ortí, J. Spertino, E. Serra, C. Baliu-Piqué, G. Melé-Ninot
10.1016/j.ad.2024.08.014